Login / Signup

Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort.

Rodrigo San-CristóbalRoberto Martín-HernándezOmar Ramos-LópezDiego Martinez-UrbistondoVíctor MicóGonzalo ColmenarejoPaula Villares FernandezLidia Daimiel RuizJosé Alfredo Martínez Hernández
Published in: Journal of clinical medicine (2022)
The use of routine laboratory biomarkers plays a key role in decision making in the clinical practice of COVID-19, allowing the development of clinical screening tools for personalized treatments. This study performed a short-term longitudinal cluster from patients with COVID-19 based on biochemical measurements for the first 72 h after hospitalization. Clinical and biochemical variables from 1039 confirmed COVID-19 patients framed on the "COVID Data Save Lives" were grouped in 24-h blocks to perform a longitudinal k-means clustering algorithm to the trajectories. The final solution of the three clusters showed a strong association with different clinical severity outcomes (OR for death: Cluster A reference, Cluster B 12.83 CI: 6.11-30.54, and Cluster C 14.29 CI: 6.66-34.43; OR for ventilation: Cluster-B 2.22 CI: 1.64-3.01, and Cluster-C 1.71 CI: 1.08-2.76), improving the AUC of the models in terms of age, sex, oxygen concentration, and the Charlson Comorbidities Index (0.810 vs. 0.871 with p < 0.001 and 0.749 vs. 0.807 with p < 0.001, respectively). Patient diagnoses and prognoses remarkably diverged between the three clusters obtained, evidencing that data-driven technologies devised for the screening, analysis, prediction, and tracking of patients play a key role in the application of individualized management of the COVID-19 pandemics.
Keyphrases